RxDoctor Payments Data

Daniel Borja Cacho, MD

Transplant Surgery · Chicago, ILNPI 1710211503

Payments from drug & device makers

What this record shows

This record is dominated by education: $11,500 of the $14,743 with a category attached, or 78.0%. Intuitive Surgical accounts for 88.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $9,101 and has fallen 94.7% since, to $481 in 2025.

$14,743in general payments, 2019–2025

Across 27 payments — averaging $546.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$13K
  • Fujifilm Healthcare Americas Corporation$906
  • Xvivo Perfusion Inc.$419
  • Sanofi-aventis U.S. LLC$109
  • Vertex$108
  • AstraZeneca$95
  • plus $75 from 1 others
$199,849in research payments, 2019–2025

Across 1 payment — averaging $199,849 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Organ Recovery Systems, Inc.$200K

What the payments were for

  • Consulting fees$6755%
  • Travel & lodging$1,3349%
  • Food & beverage$1,2338%
  • Education$11,50078%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,743 in reported general payments places this provider in the 85th percentile of 52 transplant surgery providers in Illinois.

See all transplant surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$99,444
Medicare patients
82
Services billed
186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other transplant surgery in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →